Supplementary Figure 2 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas Beatrice Gini , Ciro Zanca , Deliang Guo , Tomoo Matsutani , Kenta Masui , Shiro Ikegami , Huijun Yang , David Nathanson , Genaro R. Villa , David Shackelford , Shaojun Zhu , Kazuhiro Tanaka , Ivan Babic , David Akhavan , Kelly Lin , Alvaro Assuncao , Yuchao Gu , Bruno Bonetti , Deborah S. Mortensen , Shuichan Xu , Heather K. Raymon , Webster K. Cavenee , Frank B. Furnari , C. David James , Guido Kroemer , James R. Heath , Kristen Hege , Rajesh Chopra , Timothy F. Cloughesy , Paul S. Mischel crossref（2023）
摘要
PDF file - 5300K, CC214-1 synergizes at low doses with rapamycin. Quantification of the blots shown in Fig. 2B. PTEN detection on DEAL captured GBM39 cells upon CC214-1 treatment.
更多 查看译文
AI 理解论文
溯源树
样例
